Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P960058/S178

CLARION MULTI-STRATEGY COCHLEAR IMPLANT

Advanced Bionics · Decision date Sep 18, 2026

MEDTECHLEDGER EXPLANATIONP960058/S178

What did the FDA approve?

The FDA record lists P960058/S178 for Advanced Bionics as an approval dated 2026-09-18 on the normal 180-day track without a user fee, classified as a postapproval study protocol supplement under product code MCM. The changed item is the postapproval study (PAS) protocol itself, not the cochlear implant system's original approval. The record gives no protocol content, study design, endpoints, sample size, or timeline.

The listed statement says this PAS protocol was submitted to comply with conditions of approval in the approval order for P960058/S167. That reports the sponsor's stated purpose relative to a prior supplement; it is not independent proof of safety or clinical effectiveness, and the record does not describe S167's conditions. The descriptor 'Normal 180 Day Track No User Fee' is the review pathway and fee status, not a new device approval.

FDA approval order statement

The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P960058/S167.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Ear, Nose, Throat
Decision date
Sep 18, 2026
FDA change category
Postapproval Study Protocol

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P960058/S178
Regulatory pathway
PMA supplement
Product code
MCM
Decision code
APPR
Decision date
Sep 18, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, cochlear.

Product code
MCM
FDA device class
3

For the original device and its historical approval scope, see PMA P960058. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P960058 · Original PMA

    CLARION MULTI-STRATEGY COCHLEAR IMPLANT

  2. P960058/S178 received

    Application receipt date recorded by FDA.

  3. P960058/S177 · Related supplement

    HiResolution Bionic Ear System

  4. P960058/S178 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P960058. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960058

Product / regulatory recordCompanyPathwayDecision dateSource
Advanced BionicsPMA approvalJun 26, 1997FDA
Advanced BionicsPMA supplementSep 4, 2026FDA

Explore the linked device profile

Other records with product code MCM

Product / regulatory recordCompanyPathwayDecision dateSource
Med-El Corp.PMA supplementOct 9, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Med-El Corp.PMA approvalAug 20, 2001FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Advanced Bionics

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
28515 Westinghouse Pl., Valencia, CA, 91355

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records